A Collaborative Model for Endpoint Development for Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia

被引：13
|
作者：
Toerner, Joseph G. [1 ]
Burke, Laurie
Komo, Scott [2 ]
Papadopoulos, Elektra
机构：
[1] US FDA, Off Antimicrobial Prod, CDER, Off New Drugs, Silver Spring, MD 20993 USA
[2] US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2012年 / 55卷 / 08期
关键词：
D O I：
10.1093/cid/cis567
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1122 / 1123
页数：2
相关论文
共 50 条
  • [1] Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections
    Lodise, Thomas P.
    Low, Donald E.
    DRUGS, 2012, 72 (11) : 1473 - 1493
  • [2] Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections
    Thomas P. Lodise
    Donald E. Low
    Drugs, 2012, 72 : 1473 - 1493
  • [3] Omadacycline in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: a profile of its use
    Yvette N. Lamb
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 305 - 314
  • [4] Omadacycline in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: a profile of its use
    Lamb, Yvette N.
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (07) : 305 - 314
  • [5] Omadacycline: a therapeutic review of use in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
    Chopra, Teena
    Sandhu, Avnish
    Theriault, Nicolette
    Meehan, Joni
    Tillotson, Glenn
    FUTURE MICROBIOLOGY, 2020, 15 (14) : 1319 - 1333
  • [6] Population Pharmacokinetics of Ceftaroline in Patients With Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia
    Van Wart, Scott A.
    Forrest, Alan
    Khariton, Tatiana
    Rubino, Christopher M.
    Bhavnani, Sujata M.
    Reynolds, Daniel K.
    Riccobene, Todd
    Ambrose, Paul G.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11): : 1155 - 1167
  • [7] Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection
    Casapao, Anthony M.
    Steed, Molly E.
    Levine, Donald P.
    Rybak, Michael J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) : 1177 - 1186
  • [8] Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
    Ira M. Leviton
    Maria Amodio-Groton
    Clinical Drug Investigation, 2022, 42 : 193 - 197
  • [9] Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
    Leviton, Ira M.
    Amodio-Groton, Maria
    CLINICAL DRUG INVESTIGATION, 2022, 42 (03) : 193 - 197
  • [10] Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
    Jones, Travis M.
    Johnson, Steven W.
    DiMondi, V. Paul
    Wilson, Dustin T.
    INFECTION AND DRUG RESISTANCE, 2016, 9 : 119 - 128
12345